Discover 2,147 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,147
Active & Responsive
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
for
Myasthenia Gravis, Generalized Myasthenia Gravis
Location: Philadelphia PA, Indianapolis IN, Columbia MO, Miami FL,
Sponsor: Kyverna Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06193889
Phase2, Phase3, Recruiting
Active & Responsive
MMA Embolization for Refractory Chronic Migraine
for
Migraine Disorders
Location: Philadelphia PA, New York NY, Stony Brook NY,
Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
Sex: All
Age: 18 - 65
Code: NCT06735833
Recruiting
Active & Responsive
DILIN - Prospective Study
for
Liver Diseases
Location: Philadelphia PA, Bethesda MD, Chapel Hill NC,
Sponsor: Duke University
Sex: All
Age: 2+
Code: NCT00345930
Recruiting
Active & Responsive
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
for
Mesial Temporal Lobe Epilepsy
Location: Philadelphia PA, New York NY, Great Neck NY,
Sponsor: Neurona Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05135091
Phase3, Recruiting
Active & Responsive
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Philadelphia PA, New Brunswick NJ, New York NY,
Sponsor: Nuvation Bio Inc.
Sex: All
Age: 18+
Code: NCT05303519
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Philadelphia PA, Brooklyn NY, New York NY, Nyack NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase3, Recruiting
Active & Responsive
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
for
Human Immunodeficiency Virus (HIV),
Location: Philadelphia PA, Newark NJ, The Bronx NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 16+
Code: NCT07044297
Phase3, Recruiting
Active & Responsive
Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization
Location: Philadelphia PA, Columbus OH, Houston TX, Downey CA
Sponsor: Cyllene Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06596291
Phase1, Phase2, Recruiting
Active & Responsive
A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.
Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Philadelphia PA, Newark DE, Belleville NJ, New York NY,
Sponsor: Immuneering Corporation
Sex: All
Age: 18+
Code: NCT07562152
Phase3, Recruiting
Active & Responsive
Development of an Algorithm That Predicts Hypoventilation Due to an Opioid Overdose
for
Drug Overdose, Opioid-Related Disorders
Location: Philadelphia PA
Sponsor: RTM Vital Signs, LLC
Sex: All
Age: 18 - 40
Code: NCT03845699
Recruiting
Active & Responsive
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
for
Non-Small Cell Lung Cancer, NSCLC,
Location: Philadelphia PA, Fairfax VA, Charlotte NC, Nashville TN,
Sponsor: Pierre Fabre Medicament
Sex: All
Age: 18+
Code: NCT06043817
Phase1, Phase2, Recruiting
Active & Responsive
Surviving Daily Life
for
Stress, Cognitive Change, Breast Cancer, Breast Carcinoma,
Location: Philadelphia PA
Sponsor: Thomas Jefferson University
Sex: Female
Age: 40+
Code: NCT07054723
Recruiting
Active & Responsive
A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer
for
Non Small Cell Lung Cancer
Location: Philadelphia PA, New York NY, Buffalo NY, Pinehurst NC,
Sponsor: Ankyra Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT07027514
Phase1, Recruiting
Active & Responsive
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)